The Infectious Respiratory Disease Surveillance Dashboard from the Illinois Dept. of Public Health (IDPH) provides the latest data on hospital visits, seasonal trends, lab test positivity and demographic data. IDPH also tracks COVID-19, influenza and respiratory syncytial virus information through the Illinois Wastewater Surveillance System dashboard.

Briefly Noted

The Food and Drug Administration (FDA) has issued a notice that MediNatura New Mexico, Inc. is voluntarily recalling one lot of ReBoost Nasal Spray because the product has been found to contain yeast/mold and microbial contamination. The FDA said, "There is a reasonable probability that adverse health consequences including life-threatening infections will occur with use of the product in the immuno-compromised population." To date, MediNatura has not received any reports of adverse events related to the recall.

Leading the News

Gov. JB Pritzker signs 'right-to-die' legislation for terminally ill people to end their lives in Illinois

WGLT
Terminally ill people will have the option to end their own lives with a doctor's prescription in Illinois next year, under legislation signed by Gov. JB Pritzker on Friday. Illinois joins 11 other states and Washington, D.C., that have passed so-called "right-to-die" legislation, which is opposed by religious leaders including Chicago Cardinal Blase Cupich, as well as advocates for people with disabilities.

The health system KPIs executives pay closest attention to from 6 leaders

Becker's Hospital Review

Becker's asked six health system strategic leaders which key performance indicator they pay closest attention to when assessing system performance.

Top 10 340B drugs in 2024: Report

Becker's Hospital Review

Ten medications accounted for nearly one-third of 340B program-covered outpatient drugs in 2024, according to a Dec. 11 report.